Skip to content

Clinical trials

Phase 2 Fatty Liver trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Phase: Phase 2 Country / region: United Kingdom Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20161
20172
20181
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Axcella Health, Inc1
Enanta Pharmaceuticals, Inc1
GW Research Ltd1
GlaxoSmithKline1
Inventiva Pharma1
Ionis Pharmaceuticals, Inc.1
Jazz Pharmaceuticals1
Mirum Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver9
Non-alcoholic Fatty Liver Disease5
Diabetes Mellitus2
Diabetes Mellitus, Type 22
Fibrosis2
Liver Diseases2
Digestive System Diseases1
Dyslipidemias1
Liver Cirrhosis1
Liver Diseases, Alcoholic1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.